Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zilan Xie

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 29, 2023
Clinical potential of microbiota in thyroid cancer therapyZilan Xie, Jiating Zhou, Xuan Zhang, et al.
Journal of Cancer Research and Clinical Oncology|February 3, 2024
Exploring reciprocal causation: bidirectional mendelian randomization study of gut microbiota composition and thyroid cancerJiating Zhou, Xuan Zhang, Zilan Xie, et al.
European Journal of Pharmacology|March 6, 2025
Pharmacological modulation of cellular senescence: Implications for breast cancer progression and therapeutic strategiesJialing Xie, Xianlong Shu, Zilan Xie, et al.
Journal of Endocrinological Investigation|February 13, 2025
MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer by directly affecting the miR-27a-5p/SREBP1 axisZilan Xie, Jianqiu Liu, Jiating Zhou, et al.
Journal of Translational Medicine|May 27, 2026
CSDE1 in tumour immunology: spatiotemporal translational reprogramming and immune microenvironment remodelingDanhui Wang, Zilan Xie, Jiye Yin, et al.
Frontiers in Endocrinology|October 25, 2023
Exploring blood metabolites and thyroid disorders: a bidirectional mendelian randomization studyXuan Zhang, Jiating Zhou, Zilan Xie, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 29, 2023
Clinical potential of microbiota in thyroid cancer therapyZilan Xie, Jiating Zhou, Xuan Zhang, et al.
Journal of Cancer Research and Clinical Oncology|February 3, 2024
Exploring reciprocal causation: bidirectional mendelian randomization study of gut microbiota composition and thyroid cancerJiating Zhou, Xuan Zhang, Zilan Xie, et al.
European Journal of Pharmacology|March 6, 2025
Pharmacological modulation of cellular senescence: Implications for breast cancer progression and therapeutic strategiesJialing Xie, Xianlong Shu, Zilan Xie, et al.
Journal of Endocrinological Investigation|February 13, 2025
MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer by directly affecting the miR-27a-5p/SREBP1 axisZilan Xie, Jianqiu Liu, Jiating Zhou, et al.
Journal of Translational Medicine|May 27, 2026
CSDE1 in tumour immunology: spatiotemporal translational reprogramming and immune microenvironment remodelingDanhui Wang, Zilan Xie, Jiye Yin, et al.
Frontiers in Endocrinology|October 25, 2023
Exploring blood metabolites and thyroid disorders: a bidirectional mendelian randomization studyXuan Zhang, Jiating Zhou, Zilan Xie, et al.
Pageof 1